Severe heart failure due to chronic ischemic heart disease
Conditions
Interventions
Sponsors
Terumo Corporation
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1)Patients falling under any of the following with regard to the quality of the HeartSheet 1)When it is predicted that skeletal myoblasts do not satisfy the number of transplants assumed 2) In the sheet preparation confirmation test, when deviating from the standing time after sowing the cells (2) Patient with tissue collection using collection / subculture kit of HeartSheet (3) Patients who sign written informed consent prior to the clinical study (4) Patients who are able to undergo all scheduled observations and consent to all details of the observations.
Exclusion criteria
Exclusion criteria: (1) Patients who do not have sheets (2) Patients with a history of hypersensitivity to the components of the investigational product. (3) Patient who can not open-heart surgery. (4) Patients who are judged to be inappropriate for the study by the investigator or the sub investigators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Survival rate(Cardiac disease related death) | — |
Countries
Japan
Contacts
Public Contactkazuo tamada
Terumo Corporation Clinical Development Department
Outcome results
None listed